TrialJournal of clinical hypertension (Greenwich, Conn.)2023

Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.

Eun Joo Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.